Table 10-3.
Mechanism of Action | Drug or Treatment* | Dosage |
---|---|---|
Immunomodulator and antiviral | Feline interferon-omega (Virbagen Omega) | 1 million U/kg SC q48h until remission, then weekly |
Immunomodulator | Human interferon-alpha (Roferon, Intron-A) | 30 units PO q24h for 7 days on alternating weeks |
Anti-inflammatory and immunosuppressive | Prednisone | 2–4 mg/kg, q24h, PO |
Immunosuppressive† | Chlorambucil (Leukeran) or‡ | 20 mg/m2, every 2–3 wks, PO |
Cyclophosphamide (Cytoxan) | 2–4 mg/kg, 4 days each week, PO, or 200–300 mg/m2, every 2–3 wks, PO | |
Platelet aggregation inhibitor | Aspirin | 10 mg/kg, q72h, PO |
Ozagrel HCl | 5 mg/kg, q12h, SC | |
Topical ophthalmic for uveitis | Prednisone acetate (1%) | 2–3 drops/eye q6h |
Atropine (1%) | 1–3 drops/eye up to q6h for mydriasis | |
Supportive treatment | Minimize “stress” | — |
Parenteral fluid therapy | As needed to maintain hydration | |
Nutritional therapy via tube feeding | See Chapter 3 | |
Body cavity drainage (thoracentesis) | As needed to relieve dyspnea | |
Blood transfusion | As needed for severe anemia | |
Antibiotics for complicating infections | Dosage based on the drug |
Cats most likely to respond are in good physical condition, are eating, and are free of neurologic signs, severe anemia, and feline leukemia virus or feline immunodeficiency virus infections.
For conversion of body weight to body surface area (m2), refer to conversion tables in Chapter 26.
Choose only one of these two alkylating agents, and combine with a corticosteroid.